| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| O301 Safety of dienogest for the treatment of endometriosis: A 24-week,randomised, open-label trial versus leuprolide acetate |
Faustmann, T.;Seitz, C.;Marr, J.;Gerlinger, C.;Strowitzki, T.; |
International Journal of Gynecology & Obstetrics |
2009-10-01 |
查看 |
| O341 Minimally clinically important difference for endometriosisassociated pelvic pain measured on a visual analogue scale |
Gerlinger, C.;Schmitz, H.;Schumacher, U.;Seitz, C.; |
International Journal of Gynecology & Obstetrics |
2009-10-01 |
查看 |
| O835 Long-term experience with dienogest for the treatment ofendometriosis: a one-year, open-label, follow-up study |
Seitz, C.;Faustmann, T.;Gerlinger, C.;Strowitzki, T.; |
International Journal of Gynecology & Obstetrics |
2009-10-01 |
查看 |
| A dose-ranging study to determine the efficacy and safety of 1, 2, and4mg of dienogest daily for endometriosis |
Kohler, G.;Faustmann, T.A.;Gerlinger, C.;Seitz, C.;Mueck, A.O.; |
International Journal of Gynecology & Obstetrics |
2010-01-01 |
查看 |
| Dienogest in the treatment of endometriosis-associated pelvic pain: a12-week, randomized, double-blind, placebo-controlled study |
Strowitzki, T.;Faustmann, T.;Gerlinger, C.;Seitz, C.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2010-08-01 |
查看 |
| Dienogest in the treatment of endometriosis-associated pelvic pain: a12-week, randomized, double-blind, placebo-controlled study |
Strowitzki, T.;Faustmann, T.;Gerlinger, C.;Seitz, C.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2010-08-01 |
查看 |
| Detailed analysis of a randomized, multicenter, comparative trial ofdienogest versus leuprolide acetate in endometriosis |
Strowitzki, T.;Marr, J.;Gerlinger, C.;Faustmann, T.;Seitz, C.; |
International Journal of Gynecology & Obstetrics |
2012-06-01 |
查看 |
| A historical cycle control comparison of two drospirenone-containingcombined oral contraceptives: ethinylestradiol 30@mg/drospirenone 3mgadministered in a 21/7 regimen versus ethinylestradiol 20@mg/drospirenone3mg administered in a 24/4 regimen |
Marr, J.;Gerlinger, C.;Kunz, M.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2012-05-01 |
查看 |
|
|
